Liminal BioSciences Inc. LMNL

RE:RE:RE:RE:RE:RE:RE:Hi sah1

[stockman6767]

Gunner, you a are just playing games whether you consider fully diluted shares or not. This discussion is not worth my time, so this will be my last post on this. I know you must have the last word, so say anything you want because I will not respond further to this thread. Stockman6767   GunnerG - (10/30/2020 4:25:56 PM) RE:RE:RE:RE:RE:RE:Hi sah1 Yes the dollar value of $30M is explicit.  Its the warrants and shares I am talking about.  ???? stockman6767 wrote: Gunner, the number is explicit in the NR. It was $30 M! Stockman6767 RE:RE:RE:RE:Hi sah1 You say in a later post you used Stockman's numbers, I think you used mine.  (Stockman's)   23.6M OS + 6.3M = 29.9M OS. (GunnerG)  23.6M OS + 12.6 =  36.2M  OS sah1 wrote:The value of the Ryplazim platform and voucher remains the same. So $600M divided by 36M (assuming warrants exercised) equates to about $16. This gives zero value to the small molecule division which is consistent with current market pricing.